Fenimore Asset Management Inc. decreased its stake in Stryker Corp. (NYSE:SYK) by 1.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 532,056 shares of the medical technology company’s stock after selling 5,370 shares during the period. Stryker Corp. makes up about 3.0% of Fenimore Asset Management Inc.’s holdings, making the stock its 9th largest position. Fenimore Asset Management Inc. owned approximately 0.14% of Stryker Corp. worth $61,937,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SYK. Blue Chip Partners Inc. increased its position in Stryker Corp. by 0.3% in the second quarter. Blue Chip Partners Inc. now owns 1,757 shares of the medical technology company’s stock valued at $211,000 after buying an additional 6 shares during the last quarter. Washington Trust Bank raised its stake in Stryker Corp. by 0.5% in the second quarter. Washington Trust Bank now owns 3,040 shares of the medical technology company’s stock valued at $364,000 after buying an additional 15 shares during the last quarter. Wetherby Asset Management Inc. raised its stake in Stryker Corp. by 0.3% in the second quarter. Wetherby Asset Management Inc. now owns 6,242 shares of the medical technology company’s stock valued at $748,000 after buying an additional 18 shares during the last quarter. Douglas Lane & Associates LLC raised its stake in Stryker Corp. by 0.7% in the second quarter. Douglas Lane & Associates LLC now owns 2,945 shares of the medical technology company’s stock valued at $353,000 after buying an additional 20 shares during the last quarter. Finally, Bartlett & Co. LLC raised its stake in Stryker Corp. by 0.5% in the second quarter. Bartlett & Co. LLC now owns 5,785 shares of the medical technology company’s stock valued at $693,000 after buying an additional 30 shares during the last quarter. Hedge funds and other institutional investors own 75.49% of the company’s stock.

Institutional Ownership by Quarter for Stryker Corp. (NYSE:SYK)

Shares of Stryker Corp. (NYSE:SYK) traded up 0.23% during midday trading on Wednesday, reaching $113.99. 419,528 shares of the company were exchanged. The company has a 50 day moving average price of $115.18 and a 200-day moving average price of $114.05. Stryker Corp. has a 12-month low of $86.68 and a 12-month high of $123.55. The stock has a market capitalization of $42.67 billion, a P/E ratio of 26.87 and a beta of 0.72.

Stryker Corp. (NYSE:SYK) last released its quarterly earnings results on Thursday, July 21st. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.37 by $0.02. The business earned $2.84 billion during the quarter, compared to the consensus estimate of $2.79 billion. Stryker Corp. had a return on equity of 23.61% and a net margin of 15.33%. On average, analysts forecast that Stryker Corp. will post $5.76 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 31st. Shareholders of record on Friday, September 30th will be paid a dividend of $0.38 per share. The ex-dividend date is Wednesday, September 28th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.34%. Stryker Corp.’s dividend payout ratio is currently 35.85%.

Several analysts have recently issued reports on SYK shares. Zacks Investment Research upgraded shares of Stryker Corp. from a “hold” rating to a “buy” rating and set a $130.00 target price for the company in a research note on Tuesday, June 21st. Brean Capital reiterated a “buy” rating and issued a $125.00 target price (up previously from $121.00) on shares of Stryker Corp. in a research note on Monday, July 25th. Canaccord Genuity reiterated a “buy” rating and issued a $130.00 target price on shares of Stryker Corp. in a research note on Sunday, July 24th. Needham & Company LLC reiterated a “hold” rating on shares of Stryker Corp. in a research note on Sunday, July 24th. Finally, JPMorgan Chase & Co. reiterated a “hold” rating and issued a $119.00 target price on shares of Stryker Corp. in a research note on Friday, July 22nd. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and eleven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $114.91.

In other Stryker Corp. news, VP Yin C. Becker sold 1,111 shares of the business’s stock in a transaction dated Thursday, October 6th. The stock was sold at an average price of $117.00, for a total transaction of $129,987.00. Following the completion of the sale, the vice president now directly owns 16,939 shares in the company, valued at approximately $1,981,863. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Ronda E. Stryker sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 19th. The shares were sold at an average price of $122.11, for a total value of $1,465,320.00. Following the sale, the director now owns 193,142 shares of the company’s stock, valued at $23,584,569.62. The disclosure for this sale can be found here. Company insiders own 7.80% of the company’s stock.

About Stryker Corp.

Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties.

5 Day Chart for NYSE:SYK

Receive News & Stock Ratings for Stryker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corp. and related stocks with our FREE daily email newsletter.